Comparison

Sophoflavescenol European Partner

Item no. TMO-TN2217-25mg
Manufacturer TargetMol
CASRN 216450-65-6
Amount 25 mg
Quantity options 10 mg 1 mg 1 mL 25 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C21H20O6
Smiles COc1cc(O)c(CC=C(C)C)c2oc(c(O)c(=O)c12)-c1ccc(O)cc1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cholinesterase (ChE)|||Beta-Secretase|||BACE|||PDE|||AChR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
368.38
Description
Sophoflavescenol is a mixed inhibitor of PDE5 with a K(i) value of 0.005 microM. Sophoflavescenol has antioxidant, anti-inflammatory, and apoptotic effects , these effects might contribute to the antitumor activity without severe side effects. Sophoflavescenol exerts notable anti-inflammatory activity by inhibiting nitric oxide generation and tert-butylhydroperoxide-induced ROS generation rather than inhibiting nuclear factor kappa B activation in RAW 264.7 cells.
Pathways
Metabolism|||Neuroscience
Bioactivity
Sophoflavescenol is a mixed inhibitor of PDE5 with a K(i) value of 0.005 microM. Sophoflavescenol has antioxidant, anti-inflammatory, and apoptotic effects , these effects might contribute to the antitumor activity without severe side effects. Sophoflaves

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close